CRISPR Therapeutics AG (CRSP)
53.46
-1.18
(-2.16%)
USD |
NASDAQ |
Feb 20, 16:00
53.79
+0.33
(+0.62%)
After-Hours: 20:00
CRISPR Therapeutics Total Assets (Quarterly) : 2.265B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Beam Therapeutics, Inc. | 1.311B |
| Novartis AG | 115.57B |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| EvoNext Holdings SA | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 343.43M |
| Shareholders Equity (Quarterly) | 1.922B |
| Debt to Equity Ratio | 0.1076 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | 0.08% |